Chris Schott
Stock Analyst at J.P. Morgan
(4.13)
# 1,551
Out of 4,463 analysts
636
Total ratings
57.2%
Success rate
5.1%
Average return
Main Sectors:
Stocks Rated by Chris Schott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PFE Pfizer | Maintained: Hold | $30 | $23.88 | +25.63% | 88 | Jun 23, 2026 | |
| ABBV AbbVie | Maintained: Buy | n/a | $251.06 | - | 37 | Jun 19, 2026 | |
| TEVA Teva Pharmaceutical Industries | Maintained: Buy | n/a | $33.44 | - | 43 | Jun 15, 2026 | |
| LLY Eli Lilly and Company | Maintained: Buy | n/a | $1,191.74 | - | 70 | Jun 9, 2026 | |
| GILD Gilead Sciences | Maintained: Buy | n/a | $125.97 | - | 32 | Jun 8, 2026 | |
| REGN Regeneron Pharmaceuticals | Rated: Buy | $950 → $850 | $624.72 | +36.06% | 31 | May 18, 2026 | |
| VTRS Viatris | Rated: Hold | $17 → $18 | $16.18 | +11.25% | 27 | May 8, 2026 | |
| ZTS Zoetis | Rated: Buy | $190 → $130 | $72.45 | +79.43% | 15 | May 8, 2026 | |
| ELAN Elanco Animal Health | Rated: Buy | $28 → $30 | $24.09 | +24.53% | 21 | May 7, 2026 | |
| RPRX Royalty Pharma | Maintained: Buy | $50 → $58 | $55.78 | +3.98% | 9 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $175 → $185 | $209.74 | -11.80% | 18 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $250 → $260 | $253.98 | +2.37% | 18 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 → $135 | $125.37 | +7.68% | 33 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $16.97 | +6.07% | 19 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 → $15 | $10.31 | +45.49% | 31 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $12 → $11 | $13.53 | -18.70% | 13 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 | $56.44 | +15.17% | 40 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $675 → $775 | $537.58 | +44.16% | 15 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $300 | $361.33 | -16.97% | 11 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $8 | $1.44 | n/a | 9 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $6.99 | n/a | 41 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.16 | n/a | 3 | May 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €84.18 → €85.93 | $144.50 | n/a | 2 | Mar 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $43 → $54 | $25.03 | n/a | 4 | Feb 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 2 | May 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $1.78 | n/a | 3 | Nov 17, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $16.47 | n/a | 1 | Oct 17, 2013 |
Pfizer
Jun 23, 2026
Maintained: Hold
Price Target: $30
Current: $23.88
Upside: +25.63%
AbbVie
Jun 19, 2026
Maintained: Buy
Price Target: n/a
Current: $251.06
Upside: -
Teva Pharmaceutical Industries
Jun 15, 2026
Maintained: Buy
Price Target: n/a
Current: $33.44
Upside: -
Eli Lilly and Company
Jun 9, 2026
Maintained: Buy
Price Target: n/a
Current: $1,191.74
Upside: -
Gilead Sciences
Jun 8, 2026
Maintained: Buy
Price Target: n/a
Current: $125.97
Upside: -
Regeneron Pharmaceuticals
May 18, 2026
Rated: Buy
Price Target: $950 → $850
Current: $624.72
Upside: +36.06%
Viatris
May 8, 2026
Rated: Hold
Price Target: $17 → $18
Current: $16.18
Upside: +11.25%
Zoetis
May 8, 2026
Rated: Buy
Price Target: $190 → $130
Current: $72.45
Upside: +79.43%
Elanco Animal Health
May 7, 2026
Rated: Buy
Price Target: $28 → $30
Current: $24.09
Upside: +24.53%
Royalty Pharma
May 7, 2026
Maintained: Buy
Price Target: $50 → $58
Current: $55.78
Upside: +3.98%
Apr 24, 2026
Maintained: Hold
Price Target: $175 → $185
Current: $209.74
Upside: -11.80%
Apr 15, 2026
Maintained: Hold
Price Target: $250 → $260
Current: $253.98
Upside: +2.37%
Apr 6, 2026
Maintained: Buy
Price Target: $125 → $135
Current: $125.37
Upside: +7.68%
Mar 2, 2026
Maintained: Buy
Price Target: $18
Current: $16.97
Upside: +6.07%
Feb 27, 2026
Maintained: Hold
Price Target: $18 → $15
Current: $10.31
Upside: +45.49%
Feb 13, 2026
Maintained: Sell
Price Target: $12 → $11
Current: $13.53
Upside: -18.70%
Jan 28, 2026
Maintained: Buy
Price Target: $65
Current: $56.44
Upside: +15.17%
Nov 3, 2025
Maintained: Buy
Price Target: $675 → $775
Current: $537.58
Upside: +44.16%
Sep 16, 2025
Maintained: Hold
Price Target: $300
Current: $361.33
Upside: -16.97%
May 25, 2023
Maintained: Hold
Price Target: $9 → $8
Current: $1.44
Upside: n/a
Jul 28, 2022
Downgraded: Hold
Price Target: n/a
Current: $6.99
Upside: n/a
May 19, 2020
Downgraded: Hold
Price Target: n/a
Current: $2.16
Upside: n/a
Mar 9, 2020
Maintained: Buy
Price Target: €84.18 → €85.93
Current: $144.50
Upside: n/a
Feb 20, 2020
Maintained: Hold
Price Target: $43 → $54
Current: $25.03
Upside: n/a
May 13, 2019
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Nov 17, 2017
Maintained: Buy
Price Target: $35
Current: $1.78
Upside: n/a
Oct 17, 2013
Downgraded: Hold
Price Target: n/a
Current: $16.47
Upside: n/a